CING
CING
NASDAQ · Pharmaceuticals

Cingulate Inc

$5.02
+0.08 (+1.62%)
As of Aug 8, 2:19 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +186.5% upside
Low Target $9.95
Average Target $14.38
High Target $17.66
Current Price $5.02
Current
$5.02
Target
$14.38
$9.95 $14.38 avg $17.66
Scenario Analysis
Bear Case
$9.95
98.2%
Low target
Base Case
$14.38
+186.5%
Avg target
Bull Case
$17.66
+251.8%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$11.89
-57.8% from high
52-Week Low
$3.16
+58.9% from low
Target vs 52W High
$14.38
+20.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%